tetano
Editor, Senior Moderator
PLoS Pathog
. 2023 Mar 24;19(3):e1011240.
doi: 10.1371/journal.ppat.1011240. Online ahead of print.
Potent NKT cell ligands overcome SARS-CoV-2 immune evasion to mitigate viral pathogenesis in mouse models
Hongjia Lu[SUP] 1 2 [/SUP], Zhewei Liu[SUP] 1 [/SUP], Xiangxue Deng[SUP] 1 [/SUP], Siyang Chen[SUP] 1 [/SUP], Ruiting Zhou[SUP] 1 [/SUP], Rongqi Zhao[SUP] 1 [/SUP], Ramya Parandaman[SUP] 1 [/SUP], Amarjot Thind[SUP] 1 [/SUP], Jill Henley[SUP] 3 [/SUP], Lei Tian[SUP] 4 [/SUP], Jianhua Yu[SUP] 4 [/SUP], Lucio Comai[SUP] 1 3 [/SUP], Pinghui Feng[SUP] 5 [/SUP], Weiming Yuan[SUP] 1 [/SUP]
Affiliations
Abstract
One of the major pathogenesis mechanisms of SARS-CoV-2 is its potent suppression of innate immunity, including blocking the production of type I interferons. However, it is unknown whether and how the virus interacts with different innate-like T cells, including NKT, MAIT and γδ T cells. Here we reported that upon SARS-CoV-2 infection, invariant NKT (iNKT) cells rapidly trafficked to infected lung tissues from the periphery. We discovered that the envelope (E) protein of SARS-CoV-2 efficiently down-regulated the cell surface expression of the antigen-presenting molecule, CD1d, to suppress the function of iNKT cells. E protein is a small membrane protein and a viroporin that plays important roles in virion packaging and envelopment during viral morphogenesis. We showed that the transmembrane domain of E protein was responsible for suppressing CD1d expression by specifically reducing the level of mature, post-ER forms of CD1d, suggesting that it suppressed the trafficking of CD1d proteins and led to their degradation. Point mutations demonstrated that the putative ion channel function was required for suppression of CD1d expression and inhibition of the ion channel function using small chemicals rescued the CD1d expression. Importantly, we discovered that among seven human coronaviruses, only E proteins from highly pathogenic coronaviruses including SARS-CoV-2, SARS-CoV and MERS suppressed CD1d expression, whereas the E proteins of human common cold coronaviruses, HCoV-OC43, HCoV-229E, HCoV-NL63 and HCoV-HKU1, did not. These results suggested that E protein-mediated evasion of NKT cell function was likely an important pathogenesis factor, enhancing the virulence of these highly pathogenic coronaviruses. Remarkably, activation of iNKT cells with their glycolipid ligands, both prophylactically and therapeutically, overcame the putative viral immune evasion, significantly mitigated viral pathogenesis and improved host survival in mice. Our results suggested a novel NKT cell-based anti-SARS-CoV-2 therapeutic approach.
. 2023 Mar 24;19(3):e1011240.
doi: 10.1371/journal.ppat.1011240. Online ahead of print.
Potent NKT cell ligands overcome SARS-CoV-2 immune evasion to mitigate viral pathogenesis in mouse models
Hongjia Lu[SUP] 1 2 [/SUP], Zhewei Liu[SUP] 1 [/SUP], Xiangxue Deng[SUP] 1 [/SUP], Siyang Chen[SUP] 1 [/SUP], Ruiting Zhou[SUP] 1 [/SUP], Rongqi Zhao[SUP] 1 [/SUP], Ramya Parandaman[SUP] 1 [/SUP], Amarjot Thind[SUP] 1 [/SUP], Jill Henley[SUP] 3 [/SUP], Lei Tian[SUP] 4 [/SUP], Jianhua Yu[SUP] 4 [/SUP], Lucio Comai[SUP] 1 3 [/SUP], Pinghui Feng[SUP] 5 [/SUP], Weiming Yuan[SUP] 1 [/SUP]
Affiliations
- PMID: 36961850
- DOI: 10.1371/journal.ppat.1011240
Abstract
One of the major pathogenesis mechanisms of SARS-CoV-2 is its potent suppression of innate immunity, including blocking the production of type I interferons. However, it is unknown whether and how the virus interacts with different innate-like T cells, including NKT, MAIT and γδ T cells. Here we reported that upon SARS-CoV-2 infection, invariant NKT (iNKT) cells rapidly trafficked to infected lung tissues from the periphery. We discovered that the envelope (E) protein of SARS-CoV-2 efficiently down-regulated the cell surface expression of the antigen-presenting molecule, CD1d, to suppress the function of iNKT cells. E protein is a small membrane protein and a viroporin that plays important roles in virion packaging and envelopment during viral morphogenesis. We showed that the transmembrane domain of E protein was responsible for suppressing CD1d expression by specifically reducing the level of mature, post-ER forms of CD1d, suggesting that it suppressed the trafficking of CD1d proteins and led to their degradation. Point mutations demonstrated that the putative ion channel function was required for suppression of CD1d expression and inhibition of the ion channel function using small chemicals rescued the CD1d expression. Importantly, we discovered that among seven human coronaviruses, only E proteins from highly pathogenic coronaviruses including SARS-CoV-2, SARS-CoV and MERS suppressed CD1d expression, whereas the E proteins of human common cold coronaviruses, HCoV-OC43, HCoV-229E, HCoV-NL63 and HCoV-HKU1, did not. These results suggested that E protein-mediated evasion of NKT cell function was likely an important pathogenesis factor, enhancing the virulence of these highly pathogenic coronaviruses. Remarkably, activation of iNKT cells with their glycolipid ligands, both prophylactically and therapeutically, overcame the putative viral immune evasion, significantly mitigated viral pathogenesis and improved host survival in mice. Our results suggested a novel NKT cell-based anti-SARS-CoV-2 therapeutic approach.